Speech-Language Pathologists in Pittsburg, KS Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Mrs. Gentry A. White, M.A. CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1127 E 570th Ave, Pittsburg, KS 66762 Phone: 620-232-2990    Fax: 620-232-2844

Sandra Mcardle, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1502 E Centennial Dr, Pittsburg, KS 66762 Phone: 620-235-0020

Meena Agarwal, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1011 Ohio St, Apt A, Pittsburg, KS 66762 Phone: 620-704-5829

Southeast Kansas Speech Pathology Services, Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1800 E 4th St, Suite B, Pittsburg, KS 66762 Phone: 620-232-2990    Fax: 620-232-2844

Jeremy Griffy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 S Springdale St Apt 310, Pittsburg, KS 66762 Phone: 931-801-5604

Sean Gilmore, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1502 E Centennial Dr, Pittsburg, KS 66762 Phone: 620-235-0020

News Archive

Military sexual trauma can have mental, physical and behavioral health consequences

Military sexual trauma (MST) is defined as sexual harassment and/or sexual trauma experienced during the course of military service. It includes uninvited or unwanted verbal or physical contact of a sexual nature, such as attention, verbal remarks, touching, sexual coercion, sexual assault, and rape.

H1N1 vaccine will be approved, ready for use by September, WHO says

By September, the first H1N1 (swine) flu vaccines will be approved and ready for use, WHO director of the Initiative for Vaccine Research Marie-Paule Kieny said Thursday, Reuters reports. Kieny also expressed optimism that "vaccine production yields were improving, following a disappointing start that triggered some worries about supplies," the news service writes.

Fierce Vaccines highlights Inovio's VGX-3100 as one of 10 Promising Therapeutic Vaccines

Inovio Pharmaceuticals, Inc., which is advancing synthetic vaccines to fight cancers and infectious diseases, announced today that VGX-3100, its investigational SynCon vaccine for treating cervical dysplasia and cancer caused by human papillomavirus, was highlighted by Fierce Vaccines as one of 10 Promising Therapeutic Vaccines.

MJFF announces $1.1M for projects to develop biomarker candidates for PD

The Michael J. Fox Foundation for Parkinson's Research today announced nearly $1.1 million for projects aimed at advancing the development of leading biomarker candidates for Parkinson's disease. The discovery and validation of biomarkers is of critical importance to increasing the speed and efficiency of PD therapeutic development, allowing scientists and clinicians to more accurately identify appropriate subjects for clinical studies, measure disease progression and monitor treatment effects in clinical trials.

Read more Medical News

› Verified 9 days ago